Literature DB >> 15337862

The utility of self-report measures and the continuous performance test in the diagnosis of ADHD in adults.

Mary V Solanto1, Kennett Etefia, David J Marks.   

Abstract

BACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) occurs in as many as 4 percent of adults yet it is often not recognized in clinical settings because the presenting symptoms may resemble those seen in other disorders or because symptoms may be masked by commonly comorbid conditions such as anxiety and depression.
OBJECTIVE: The purpose of this study was to examine the diagnostic utility of instruments commonly used in the assessment of adults presenting with symptoms of ADHD.
METHODS: We reviewed several widely used self-report and laboratory measures and empirically examined the utility of the Brown Attention-Deficit Disorder Scale for Adults (Brown ADD Scale) and the Conners Continuous Performance Test (CPT) in differentially identifying adults with ADHD and those with other Axis I disorders.
RESULTS: Ninety-three adults who self-referred to the ADHD program for adults at a university medical center participated in the study. Of these, 44 had ADHD combined subtype (ADHD-CB), and 26 had ADHD, predominantly inattentive subtype (ADHD-IA). Thirty-three non-ADHD adults diagnosed with Axis I mood or anxiety disorders comprised an "Other Psychiatric" group. Rates of comorbid disorders, including substance abuse, in the ADHD groups were typical of those reported in the adult ADHD literature. Data on the Brown ADD Scale and on the CPT were available for subsets of 61 and 46 participants, respectively. Analyses showed that the ADHD-CB, ADHD-IA, and Other Psychiatric groups all received mean scores in the clinical range on the Brown ADD Scale, with a trend toward even higher elevations in the two ADHD groups. Among 12 CPT variables assessed for the three groups, the mean scores on only two variables for the ADHD-IA group were clinically elevated. Neither the Brown ADD Scale nor CPT scores evinced sufficient sensitivity and specificity to qualify them to assist in differential diagnosis of ADHD vis-a-vis other, predominantly internalizing, psychiatric disorders.
CONCLUSION: The results indicate a need for closer examination of executive and adaptive functioning in adults with ADHD compared with those with internalizing disorders in order to identify features that could assist in differential diagnosis.

Entities:  

Mesh:

Year:  2004        PMID: 15337862     DOI: 10.1017/s1092852900001929

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  10 in total

1.  Symptoms of attention-deficit/hyperactivity disorder in long-term survivors of childhood leukemia.

Authors:  Kevin R Krull; Raja B Khan; Kirsten K Ness; Davonna Ledet; Liang Zhu; Ching-Hon Pui; Scott C Howard; Deo Kumar Srivastava; Noah D Sabin; Melissa M Hudson; E Brannon Morris
Journal:  Pediatr Blood Cancer       Date:  2011-01-28       Impact factor: 3.167

2.  Reliability and validity of self- and other-ratings of symptoms of ADHD in adults.

Authors:  Elizabeth E Van Voorhees; Kristina K Hardy; Scott H Kollins
Journal:  J Atten Disord       Date:  2010-04-27       Impact factor: 3.256

3.  [Attention deficit-hyperactivity disorder (ADHD) and comorbid mental disorders : ADHD-specific self-rating scales in differential diagnostics].

Authors:  M Paucke; T Stark; C Exner; C Kallweit; U Hegerl; M Strauß
Journal:  Nervenarzt       Date:  2018-11       Impact factor: 1.214

Review 4.  Toward Precision Medicine in ADHD.

Authors:  Jan Buitelaar; Sven Bölte; Daniel Brandeis; Arthur Caye; Nina Christmann; Samuele Cortese; David Coghill; Stephen V Faraone; Barbara Franke; Markus Gleitz; Corina U Greven; Sandra Kooij; Douglas Teixeira Leffa; Nanda Rommelse; Jeffrey H Newcorn; Guilherme V Polanczyk; Luis Augusto Rohde; Emily Simonoff; Mark Stein; Benedetto Vitiello; Yanki Yazgan; Michael Roesler; Manfred Doepfner; Tobias Banaschewski
Journal:  Front Behav Neurosci       Date:  2022-07-06       Impact factor: 3.617

5.  Influence of the COMT val(108/158)met polymorphism on continuous performance task indices.

Authors:  Yunsoo Park; Irwin D Waldman
Journal:  Neuropsychologia       Date:  2014-06-16       Impact factor: 3.139

6.  The impact of a computerised test of attention and activity (QbTest) on diagnostic decision-making in children and young people with suspected attention deficit hyperactivity disorder: single-blind randomised controlled trial.

Authors:  Chris Hollis; Charlotte L Hall; Boliang Guo; Marilyn James; Janet Boadu; Madeleine J Groom; Nikki Brown; Catherine Kaylor-Hughes; Maria Moldavsky; Althea Z Valentine; Gemma M Walker; David Daley; Kapil Sayal; Richard Morriss
Journal:  J Child Psychol Psychiatry       Date:  2018-04-26       Impact factor: 8.982

7.  Use of machine learning to classify adult ADHD and other conditions based on the Conners' Adult ADHD Rating Scales.

Authors:  Hanna Christiansen; Mira-Lynn Chavanon; Oliver Hirsch; Martin H Schmidt; Christian Meyer; Astrid Müller; Hans-Juergen Rumpf; Ilya Grigorev; Alexander Hoffmann
Journal:  Sci Rep       Date:  2020-11-02       Impact factor: 4.379

8.  Neuropsychological functioning of individuals at clinical evaluation of adult ADHD.

Authors:  Nana Guo; Anselm B M Fuermaier; Janneke Koerts; Bernhard W Mueller; Katerina Diers; Aaron Mroß; Christian Mette; Lara Tucha; Oliver Tucha
Journal:  J Neural Transm (Vienna)       Date:  2020-12-23       Impact factor: 3.850

9.  Linear and non-linear analyses of Conner's Continuous Performance Test-II discriminate adult patients with attention deficit hyperactivity disorder from patients with mood and anxiety disorders.

Authors:  Ole Bernt Fasmer; Kristin Mjeldheim; Wenche Førland; Anita L Hansen; Vigdis Elin Giæver Syrstad; Ketil J Oedegaard; Jan Øystein Berle
Journal:  BMC Psychiatry       Date:  2016-08-11       Impact factor: 3.630

10.  Protocol investigating the clinical utility of an objective measure of attention, impulsivity and activity (QbTest) for optimising medication management in children and young people with ADHD 'QbTest Utility for Optimising Treatment in ADHD' (QUOTA): a feasibility randomised controlled trial.

Authors:  Charlotte L Hall; Marilyn James; Sue Brown; Jennifer L Martin; Nikki Brown; Kim Selby; Julie Clarke; Hena Vijayan; Boliang Guo; Kapil Sayal; Chris Hollis; Madeleine J Groom
Journal:  BMJ Open       Date:  2018-02-15       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.